Legend
Please note that a short description of a certain column can be displayed when you move your mouse cursor over the column's header and hold it still. Below, a more detailed description is shown per column.
Effect : The variant's effect on the function of the gene/protein, displayed in the format 'R/C'. R is the value reported by the source (publication, submitter) and this classification may vary between records. C is the value concluded by the curator. Note that in some database the curator uses Summary records to give details on the classification of the variant.Values used: '+' indicating the variant affects function, '+?' probably affects function, '-' does not affect function, '-?' probably does not affect function, '?' effect unknown, '.' effect was not classified.
Exon : number of exon/intron containing variant; 2 = exon 2, 12i = intron 12, 2i_7i = from intron 2 to intron 7, 8i_9 = intron 8/exon 9 boundary, _1 = 5' to exon 1, 18_ = 3' of exon 18, _1_18_ = encompassing the entire 18-exon gene
DNA change (cDNA) : description of variant at DNA level, based on a coding DNA reference sequence (following HGVS recommendations); e.g. c.123C>T, c.123_145del, c.123_126dup. For deletions/duplications extending beyond the reference transcript resp. {0}/{2} is used to replace del/dup. Extent of the deletion/duplication should be specified using the genomic description (g.). "-" indicates the variant described on genomic level does not affect the coding DNA reference sequence.
RNA change : description of variant at RNA level (following HGVS recommendations).
r.123c>u
r.? = unknown
r.(?) = RNA not analysed but probably transcribed copy of DNA variant
r.spl? = RNA not analysed but variant probably affects splicing
r.(spl?) = RNA not analysed but variant may affect splicing
r.0? = change expected to abolish transcription
Protein : description of variant at protein level (following HGVS recommendations).
p.(Arg345Pro) = change predicted from DNA (RNA not analysed)
p.Arg345Pro = change derived from RNA analysis
p.? = unknown effect
p.0? = probably no protein produced
Allele : On which allele is the variant located? Does not necessarily imply inheritance! 'Paternal' (confirmed or inferred), 'Maternal' (confirmed or inferred), 'Parent #1' or #2 for compound heterozygosity without having screened the parents, 'Unknown' for heterozygosity without having screened the parents, 'Both' for homozygozity.
Classification method : The method used for the clinical classification of this variant.
All options:
ACMG
ACGS
EAHAD-CFDB
ENIGMA
IARC
InSiGHT
kConFab
other
Clinical classification : Clinical classification of variant, preferably based on standardised criteria (e.g. ACMG), directed on the clinical consequences as published/submitted, indicated using an enriched system including inheritance: e.g. pathogenic, pathogenic (dominant), pathogenic (recessive), pathogenic (!), pathogenic (maternal), pathogenic (paternal). Standard inheritance is covered by dominant/recessive, imprinting by maternal/paternal. A '!' warns for exceptional circumstances to be explained in the 'Remarks' field (low penetrance, variants pathogenic in heterozygous state only, hypomorphic/hypermorphic variants, protective variants, etc.). Non-disease consequences (e.g. drug metabolism (pharmacogenetics), risk factor, blood group, tasting bitter) are indicated using additions to the benign classification; benign (dominant), benign (recessive), benign (!), etc. The value 'association' is used for variants associated with a phenotype and 'NA' for variants from in vitro/in silico records. NOTE: classification may differ from the opinion of the curator as given in a variant SUMMARY-record or the 'Functional effect concluded'). NOTE: pathogenic/likely pathogenic should go together with "variant (probably) affects function" In ClassFunctional.
All options:
pathogenic
pathogenic (dominant)
pathogenic (recessive)
pathogenic (!)
pathogenic (maternal)
pathogenic (paternal)
likely pathogenic
likely pathogenic (dominant)
likely pathogenic (recessive)
likely pathogenic (!)
likely pathogenic (maternal)
likely pathogenic (paternal)
VUS
VUS (!)
likely benign
likely benign (dominant)
likely benign (recessive)
likely benign (!)
likely benign (maternal)
likely benign (paternal)
benign
benign (dominant)
benign (recessive)
benign (!)
benign (maternal)
benign (paternal)
association
unclassified
NA
DNA change (genomic) (hg19) : HGVS description of variant at DNA level, based on the genomic (chromosomal) DNA reference sequence; e.g. g.12345678C>T, g.12345679del, g.12345678_12345890dup
DNA change (hg38) : HGVS description of variant at DNA level, based on the hg38 genomic (chromosomal) eference sequence; e.g. g.12345678C>T, g.12345679del, g.12345678_12345890dup
Published as : listed only when different from "DNA change"; variant as reported originally (e.g. 521delT). Variants seen in animal models, tested in vitro, predicted from RNA analysis, etc. are described between brackets like c.(456C>G)
ISCN : description of the variant according to ISCN nomenclature
DB-ID : database ID of variant, grouping multiple observations of the same variant together, starting with the HGNC gene symbol, followed by an underscore (_) and a six digit number (e.g. DMD_012345). _000000 is used for variants where DNA was not analysed (change predicted from RNA analysis), variants seen in animal models or variants not seen in humans but functionally tested in vitro
Variant remarks : remarks regarding variant described, e.g. germline mosaicism in mother, 345 kb deletion, muscle RNA analysed, not in 200 control chromosomes tested, on founder haplotype, etc.
Reference : publication describing the variant submitted, incl. links to OMIM, PubMed or other source, e.g. "den Dunnen ASHG2003 P2346"
ClinVar ID : ID of variant in ClinVar database
dbSNP ID : the dbSNP ID
Origin : Origin of variant/record: Germline = in all cells, De novo = in all cells, but not in either parent, Germline/De novo (untested) = in all cells, parents not tested (use only when De novo is likely, e.g. isolated/sporadic cases with dominant disease), Somatic = present in a subset of cells, but not in either parent, Uniparental disomy = from parental disomy (maternal or paternal), CLASSIFICATION record = submitter only sharing variant classification (note another report may share Individual data), SUMMARY record = master summary record from curator (may link to another database), In vitro (cloned) = data resulting from in vitro functional assays, animal model = data from animal model, Artefact = false positive variant call, DUPLICATE record = variant already described on another chromosome (e.g. unbalanced translocation, duplicating transposition, 2nd fusion transcript, etc.)
All options:
Germline
De novo
Germline/De novo (untested)
Somatic
Uniparental disomy
Uniparental disomy, maternal allele
Uniparental disomy, paternal allele
CLASSIFICATION record
SUMMARY record
In vitro (cloned)
In silico
animal model
Artefact
DUPLICATE record
Unknown
Not applicable
Segregation : Indicates whether the variant segregates with the phenotype (yes), does not segregate with the phenotype (no) or segregation is unknown (?)
All options:
? = unknown
yes = segregates with phenotype
no = does not segregate with phenotype
- = not applicable
Frequency : frequency in which the variant was found; e.g 5/760 chromosomes (in 5 of 760 chromosomes tested), 1/33 patients (in 1 of 33 patients analysed in study), 0.05 controls (in 5% of control cases tested)
Re-site : restriction enzyme recognition site created (+) or destroyed (-); e.g. BglII+;BamHI-
VIP : variant VIP-status was requested for matchmaking - need collaboration(s) to crack the case - please contact the submitter/curator.
NOTE: to get VIP status ask the curator.
Methylation : result of methylation test; GOM (gain of methylation), LOM (loss of methylation), 30% (30% methylated). NOTE: when several tests were done mention the method as well (e.g. MS-PCR 75%)
Effect
Exon
DNA change (cDNA)
RNA change
Protein
Classification method
Clinical classification
DNA change (genomic) (hg19)
DNA change (hg38)
Published as
ISCN
DB-ID
Variant remarks
Reference
ClinVar ID
dbSNP ID
Origin
Segregation
Frequency
Re-site
VIP
Methylation
Owner
+/.
5i_6i
c.(537+1_538-1)_(705+1_706-1)
r.?
p?
-
pathogenic
g.(6037055_6038738)_(6038907_6042083)del
-
-
-
PMS2_000293
-
-
-
-
Germline
-
-
-
-
-
José Luis Soto
-/-
_1
c.-2559T>A
r.(?)
p.(=)
-
benign
g.6051209A>T
g.6011578A>T
-
-
PMS2_000158
Insight class: 1
-
-
-
SUMMARY record
-
-
-
-
-
InSiGHT - John-Paul Plazzer
?/.
_1
c.-2559T>A
r.(=)
p.(=)
-
VUS
g.6051209A>T
g.6011578A>T
-
-
PMS2_000158
-2472 from transcription start site
PubMed: Jeske 2008
-
-
Germline
-
-
-
-
-
Michael Woods
-/-
_1
c.-2146C>A
r.(?)
p.(=)
-
benign
g.6050796G>T
g.6011165G>T
-
-
PMS2_000136
Insight class: 1
-
-
-
SUMMARY record
-
-
-
-
-
InSiGHT - John-Paul Plazzer
?/.
_1
c.-2146C>A
r.(=)
p.(=)
-
VUS
g.6050796G>T
g.6011165G>T
-
-
PMS2_000136
-2059 from the transcription start site
PubMed: Jeske 2008
-
-
Germline
-
-
-
-
-
Michael Woods
?/?
_1
c.-963A>G
r.(?)
p.(=)
-
VUS
g.6049613T>C
g.6009982T>C
-
-
PMS2_000199
Insight class: 3
-
-
-
SUMMARY record
-
-
-
-
-
InSiGHT - John-Paul Plazzer
?/.
_1
c.-963A>G
r.(?)
p.(=)
-
VUS
g.6049613T>C
g.6009982T>C
-
-
PMS2_000199
-876 from the transcription start site; allele possibly playing a functional role in familial hyperaldosteronism type II (FH-II)
PubMed: Jeske 2008
-
-
Germline
-
-
-
-
-
Michael Woods
?/?
_1
c.-340G>T
r.(?)
p.(=)
-
VUS
g.6048990C>A
g.6009359C>A
-
-
PMS2_000001
Insight class: 3
-
-
-
SUMMARY record
-
-
-
-
-
InSiGHT - John-Paul Plazzer
?/.
_1
c.-340G>T
r.(?)
p.(=)
-
VUS
g.6048990C>A
g.6009359C>A
-
-
PMS2_000001
-
PubMed: Hendriks 2006
-
-
Germline
-
-
-
-
-
Juul Wijnen
-/-
_1
c.-323G>T
r.(?)
p.(=)
-
benign
g.6048973C>A
g.6009342C>A
-
-
PMS2_000002
Insight class: 1
-
-
-
SUMMARY record
-
-
-
-
-
InSiGHT - John-Paul Plazzer
?/.
_1
c.-323G>T
r.(=)
p.(=)
-
VUS
g.6048973C>A
g.6009342C>A
-
-
PMS2_000002
-
PubMed: Hendriks 2006
-
-
Germline
-
-
-
-
-
Juul Wijnen
-/-
_1
c.-195T>C
r.(?)
p.(=)
-
benign
g.6048845A>G
g.6009214A>G
-
-
PMS2_000003
Insight class: 1
-
-
-
SUMMARY record
-
-
-
-
-
InSiGHT - John-Paul Plazzer
?/.
_1
c.-195T>C
r.(=)
p.(=)
-
VUS
g.6048845A>G
g.6009214A>G
-
-
PMS2_000003
-
PubMed: Hendriks 2006
-
-
Germline
-
-
-
-
-
Juul Wijnen
?/.
_1
c.-195T>C
r.(=)
p.(=)
-
VUS
g.6048845A>G
g.6009214A>G
-
-
PMS2_000003
-
PubMed: Thompson 2004
-
-
Germline
-
-
-
-
-
Michael Woods
-/-
_1
c.-154C>G
r.(?)
p.(=)
-
benign
g.6048804G>C
g.6009173G>C
-
-
PMS2_000004
Insight class: 1
-
-
-
SUMMARY record
-
-
-
-
-
InSiGHT - John-Paul Plazzer
-/.
1
c.-154C>G
r.(?)
p.(=)
-
benign
g.6048804G>C
g.6009173G>C
-
-
PMS2_000004
-
contributed by Dept. of Dr Vaccaro
-
-
Germline
-
-
-
-
-
CEMIC - Genotyping - Angela Solano
-/.
1
c.-154C>G
r.(?)
p.(=)
-
benign
g.6048804G>C
g.6009173G>C
-
-
PMS2_000004
-
contributed by Dept. of Dr Vaccaro
-
-
Germline
-
-
-
-
-
CEMIC - Genotyping - Angela Solano
-/.
1
c.-154C>G
r.(?)
p.(=)
-
benign
g.6048804G>C
g.6009173G>C
-
-
PMS2_000004
-
contributed by Dept. of Dr Vaccaro
-
-
Germline
-
-
-
-
-
CEMIC - Genotyping - Angela Solano
-/.
1
c.-154C>G
r.(?)
p.(=)
-
benign
g.6048804G>C
g.6009173G>C
-
-
PMS2_000004
-
contributed by Dept. of Dr Vaccaro
-
-
Germline
-
-
-
-
-
CEMIC - Genotyping - Angela Solano
?/.
_1
c.-154C>G
r.(=)
p.(=)
-
VUS
g.6048804G>C
g.6009173G>C
-
-
PMS2_000004
-
PubMed: Hendriks 2006
-
-
Germline
-
-
-
-
-
Juul Wijnen
?/.
_1
c.-154C>G
r.(=)
p.(=)
-
VUS
g.6048804G>C
g.6009173G>C
-
-
PMS2_000004
-
PubMed: Thompson 2004
-
-
Germline
-
-
-
-
-
Michael Woods
-/.
-
c.-154C>G
r.(?)
p.(=)
-
benign
g.6048804G>C
g.6009173G>C
-
-
PMS2_000004
-
-
-
-
Germline
-
-
-
-
-
Carlos Vaccaro
-/.
-
c.-154C>G
r.(?)
p.(=)
-
benign
g.6048804G>C
g.6009173G>C
-
-
PMS2_000004
-
-
-
-
Germline
-
-
-
-
-
Carlos Vaccaro
?/.
_1
c.-120del
r.(?)
p.(=)
-
VUS
g.6048773del
g.6009142del
-
-
PMS2_000052
-
PubMed: Miyaki 1997
-
-
Somatic
-
-
-
-
-
Michael Woods
?/?
_1
c.-101A>G
r.(?)
p.(=)
-
VUS
g.6048751T>C
g.6009120T>C
-
-
PMS2_000005
Insight class: 3
-
-
-
SUMMARY record
-
-
-
-
-
InSiGHT - John-Paul Plazzer
?/.
_1
c.-101A>G
r.(?)
p.(=)
-
VUS
g.6048751T>C
g.6009120T>C
-
-
PMS2_000005
-
PubMed: Hendriks 2006
-
-
Germline
-
-
-
-
-
Juul Wijnen
-/-
_1
c.-93G>A
r.(?)
p.(=)
-
benign
g.6048743C>T
g.6009112C>T
-
-
PMS2_000241
Insight class: 1
-
-
-
SUMMARY record
-
-
-
-
-
InSiGHT - John-Paul Plazzer
-?/.
_1
c.-93G>A
r.(=)
p.(=)
-
likely benign
g.6048743C>T
g.6009112C>T
-
-
PMS2_000241
allele is trancsribed
-
-
-
Germline
-
-
-
-
-
Carli Tops
-/.
1
c.-93G>C
r.(?)
p.(=)
-
benign
g.6048743C>G
g.6009112C>G
-
-
PMS2_000448
-
contributed by Dept. of Dr Vaccaro
-
-
Germline
-
-
-
-
-
CEMIC - Genotyping - Angela Solano
-/.
-
c.-93G>C
r.(?)
p.(=)
-
benign
g.6048743C>G
-
-
-
PMS2_000448
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
VKGL-NL_Nijmegen
-/.
-
c.-93G>T
r.(?)
p.(=)
-
benign
g.6048743C>A
-
-
-
AIMP2_000014
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
VKGL-NL_Nijmegen
+/+
1i_2i
c.(?_-87)_(23+1_24-1)del
r.0?
p.0?
-
pathogenic
g.(6045663_6048627)_(6048737_?)del
-
-
-
PMS2_000044
Insight class: 5
-
-
-
SUMMARY record
-
-
-
-
-
InSiGHT - John-Paul Plazzer
+/.
1
c.(?_-87)_(23+1_24-1)del
r.(?)
p.?
-
pathogenic
g.(6045663_6048627)_(6048737_?)del
-
Deletion of Exon 1
-
PMS2_000044
-
PubMed: Senter 2008
-
-
Germline
-
-
-
-
-
Michael Woods
+/+
_1_10i
c.(?_-87)_(1144+1_1145-1)del
r.0?
p.0?
-
pathogenic
g.(6027252_6029430)_(6048737_?)del
-
-
-
PMS2_000179
Insight class: 5
-
-
-
SUMMARY record
-
-
-
-
-
InSiGHT - John-Paul Plazzer
+/.
_1_10i
c.(?_-87)_(1144+1_1145-1)del
r.(?)
p.?
-
pathogenic
g.(6027252_6029430)_(6048737_?)del
-
del ex01-10
-
PMS2_000179
-
-
-
-
Germline
-
-
-
-
-
Peter Propping, Prof. Dr. med.
+/.
_1_10i
c.(?_-87)_(1144+1_1145-1)del
r.(?)
p.?
-
pathogenic
g.(6027252_6029430)_(6048737_?)del
-
ex01_ex10del
-
PMS2_000179
-
-
-
-
Germline
-
-
-
-
-
Beate Dr. Betz
+/.
_1_12i
c.(?_-87)_(2174+1_2175-1)del
r.?
p.?
-
pathogenic
g.(6018328_6022454)_(6048737_?)del
-
c.-87-?_2174+?del/Del exon 1-12
-
PMS2_000366
-
-
-
-
Germline
-
-
-
-
-
Thomas Hansen
+/.
_1_14i
c.(?_-87)_(2445+1_2446-1)del
r.?
p.?
-
pathogenic
g.(6013174_6017218)_(6048737_?)del
-
c.-87-?_2445+?del /Deletion af exon 1-14
-
PMS2_000367
-
-
-
-
Germline
-
-
-
-
-
Thomas Hansen
+/+
_1_15_
c.(?_-87)_(*160_?)del
r.0?
p.0?
-
pathogenic
g.(?_6012870)_(6048737_?)del
-
-
-
PMS2_000007
Insight class: 5
-
-
-
SUMMARY record
-
-
-
-
-
InSiGHT - John-Paul Plazzer
+/.
_1_15_
c.(?_-87)_(*160_?)del
r.(?)
p.?
-
pathogenic
g.(?_6012870)_(6048737_?)del
-
del ex1_15
-
PMS2_000007
-
PubMed: van der Klift 2005 , PubMed: Hendriks 2006
-
-
Germline
-
-
-
-
-
Juul Wijnen
+/.
_1_15_
c.(?_-87)_(*160_?)del
r.(?)
p.?
-
pathogenic
g.(?_6012870)_(6048737_?)del
-
Deletion of Exon 1-15
-
PMS2_000007
-
PubMed: Senter 2008 ; PubMed: Tomsic 2012
-
-
Germline
-
-
-
-
-
Michael Woods
+/.
_1_15_
c.(?_-87)_(*160_?)del
r.(?)
p.?
-
pathogenic
g.(?_6012870)_(6048737_?)del
-
Deletion of Exon 1-15
-
PMS2_000007
-
PubMed: Senter 2008 ; PubMed: Tomsic 2012
-
-
Germline
-
-
-
-
-
Michael Woods
+/.
_1_15_
c.(?_-87)_(*160_?)del
r.(?)
p.?
-
pathogenic
g.(?_6012870)_(6048737_?)del
-
deletion of Exon1-15 and duplication of 3' related gene (c.1-?_2589?del).
-
PMS2_000007
-
PubMed: Hendriks 2006
-
-
Germline
-
-
-
-
-
Michael Woods
+/.
_1_15_
c.(?_-87)_(*160_?)del
r.(?)
p.?
-
pathogenic
g.(?_6012870)_(6048737_?)del
-
Deletion of PMS2
-
PMS2_000007
-
PubMed: Overbeek 2007 ; PubMed: Tomsic 2012
-
-
Germline
-
-
-
-
-
Michael Woods
+/.
_1_15_
c.(?_-87)_(*160_?)del
r.(?)
p.?
-
pathogenic
g.(?_6012870)_(6048737_?)del
-
del ex 1-15, dupPMS2CL
-
PMS2_000007
-
PubMed: van der Klift 2010
-
-
Germline
-
-
-
-
-
Carli Tops
+/.
_1_15_
c.(?_-87)_(*160_?)del
r.(?)
p.?
-
pathogenic
g.(?_6012870)_(6048737_?)del
-
PMS2 exon 1-15 del
-
PMS2_000007
-
PubMed: Thompson 2013 ; PubMed: Tomsic 2012 ; PubMed: Senter 2008
-
-
Germline
-
-
-
-
-
Mark Jenkins
+/.
_1_15_
c.(?_-87)_(*160_?)del
r.(?)
p.?
-
pathogenic
g.(?_6012870)_(6048737_?)del
-
MLH1:c.198C>T; PMS2:c.(?_-87)_(*160_?)del
-
PMS2_000007
-
Mark Jenkins
-
-
Germline
-
-
-
-
-
INSiGHT group
+/.
_1_15_
c.(?_-87)_(*160_?)del
r.?
p.?
-
pathogenic
g.(?_6012870)_(6048737_?)del
-
c.1-?_2586+?del Whole gene deletion
-
PMS2_000007
-
PubMed: Lagerstedt-Robinson 2016
-
-
Germline
-
-
-
-
-
Kristina Lagerstedt Robinson
?/.
1
c.-77del
r.(?)
p.(=)
-
VUS
g.6048727del
g.6009096del
-
-
PMS2_000374
-
-
-
-
Unknown
-
-
-
-
-
Barbara Luisa Soares
?/.
1
c.-53G>A
r.(=)
p.(=)
-
VUS
g.6048703C>T
g.6009072C>T
c.-53G>A
-
PMS2_000375
-
-
-
-
Germline
-
-
-
-
-
Thomas Hansen
-/.
-
c.-53G>A
r.(?)
p.(=)
-
benign
g.6048703C>T
-
-
-
PMS2_000375
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
VKGL-NL_Nijmegen
-?/.
-
c.-43A>G
r.(?)
p.(=)
-
likely benign
g.6048693T>C
g.6009062T>C
-
-
AIMP2_000005
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
VKGL-NL_Nijmegen
+?/.
10i_15_
c.(1144+1_1145-1)_*160{0}
r.?
p.?
ACMG
likely pathogenic
g.(?_5996249)_(6027252_6029430)del
g.(?_5956618)_(5987621_5989799)del
del ex11-15
-
PMS2_000512
deletion PMS2 NG_008466.1(NM_000535.5):c.(1144+1_1145-1)_(*16781_?)del
PubMed: Arnold 2020
-
-
Germline
?
-
-
-
-
Andreas Laner
+?/.
_1_10i
c.-87_(1144+1_1145-1){0}
r.0?
p.0?
ACMG
likely pathogenic
g.(6027252_6029430)_(6078750_?)del
g.(5987621_5989799)_(6039119_?)del
del ex 1-10 c.(?_-30100)_(144+1_145-1)del
-
PMS2_001010
-
PubMed: Arnold 2020
-
-
Germline
?
-
-
-
-
Andreas Laner
?/.
1
c.1A>G
r.(?)
p.(Met1?)
-
VUS
g.6048650T>C
g.6009019T>C
-
-
PMS2_000256
-
-
-
-
Germline
-
-
-
-
-
Arjen Mensenkamp
+?/.
-
c.1A>G
r.(?)
p.(Met1?)
-
likely pathogenic
g.6048650T>C
g.6009019T>C
PMS2(NM_001322014.1):c.1A>G (p.M1?)
-
PMS2_000256
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
VKGL-NL_Nijmegen
+?/.
1
c.1A>G
r.(?)
p.(Met1?)
-
likely pathogenic
g.6048650T>C
g.6009019T>C
-
-
PMS2_000256
-
PubMed: Senter 2008
-
-
Germline
-
-
-
-
-
Michael Woods
+?/.
1
c.1A>G
r.(?)
p.(Met1?)
-
likely pathogenic
g.6048650T>C
g.6009019T>C
-
-
PMS2_000256
-
PubMed: Senter 2008
-
-
Germline
-
-
-
-
-
Michael Woods
+?/.
1
c.1A>G
r.(?)
p.(Met1?)
-
likely pathogenic
g.6048650T>C
g.6009019T>C
-
-
PMS2_000256
-
PubMed: Senter 2008
-
-
Germline
-
-
-
-
-
Michael Woods
+?/.
1
c.1A>G
r.(?)
p.(Met1?)
-
likely pathogenic
g.6048650T>C
g.6009019T>C
-
-
PMS2_000256
-
PubMed: Borras 2013
-
-
Germline
-
-
-
-
-
Gabriel Capella
+?/.
1
c.1A>G
r.(?)
p.(Met1?)
-
likely pathogenic
g.6048650T>C
g.6009019T>C
c.1A>G
-
PMS2_000256
-
Mark Jenkins; John Hopper
-
-
Germline
-
-
-
-
-
INSiGHT group
+?/.
1
c.1A>G
r.(?)
p.(Met1?)
-
likely pathogenic
g.6048650T>C
g.6009019T>C
c.1A>G
-
PMS2_000256
-
Mark Jenkins; John Hopper
-
-
Germline
-
-
-
-
-
INSiGHT group
+/.
1
c.1A>G
r.(?)
p.(Met1?)
-
pathogenic
g.6048650T>C
g.6009019T>C
-
-
PMS2_000256
-
Ian Berry, Leeds Genetics Laboratory
-
-
Germline
-
-
-
-
-
Ian Berry
+?/.
1
c.1A>G
r.(?)
p.Met1Val
-
likely pathogenic
g.6048650T>C
g.6009019T>C
c.1A>G
-
PMS2_000256
-
-
-
-
Germline
-
-
-
-
-
Thomas Hansen
+/.
1
c.1A>G
r.(?)
p.0?
-
pathogenic
g.6048650T>C
g.6009019T>C
-
-
PMS2_000256
ICCON data, Westmead, NSW
-
-
-
Germline
-
-
-
-
-
InSiGHT - John-Paul Plazzer
+/+?
-
c.1A>G
r.(?)
p.(Met1?)
-
likely pathogenic
g.6048650T>C
g.6009019T>C
-
-
PMS2_000256
Insight class: 4
-
-
-
Germline/De novo (untested)
-
-
-
-
-
Grigorij Yanus
?/.
-
c.1A>G
r.(?)
p.(Met1?)
-
VUS
g.6048650T>C
-
PMS2(NM_001322014.1):c.1A>G (p.M1?)
-
PMS2_000256
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
VKGL-NL_Rotterdam
?/.
-
c.1A>G
r.?
p.?
-
NA
g.6048650T>C
-
chr7_6048650_T_C
-
PMS2_000256
the study was not designed to clinically classify individual variants but performed burden-type association analyses, grouping certain variant types
PubMed: Dorling 2021 , Journal: Dorling 2021
-
-
Germline
-
6/60466 cases
-
-
-
BRIDGES consortium
?/.
-
c.1A>G
r.?
p.?
-
NA
g.6048650T>C
-
chr7_6048650_T_C
-
PMS2_000256
the study was not designed to clinically classify individual variants but performed burden-type association analyses, grouping certain variant types
PubMed: Dorling 2021 , Journal: Dorling 2021
-
-
Germline
-
3/53461 controls
-
-
-
BRIDGES consortium
+?/+?
1
c.2T>A
r.(?)
p.(Met1?)
ACMG
likely pathogenic
g.6048649A>T
g.6009018A>T
-
-
PMS2_000017
ACMG grading: PVS1, PM2, PM3, PP4, PP5 class 5 (Literature:PMID 27476653; PMID 26681312; PMID 28466842)
-
-
rs587780059
Germline
?
-
-
-
-
Andreas Laner
?/.
1
c.2T>A
r.(?)
p.0?
-
VUS
g.6048649A>T
g.6009018A>T
-
-
PMS2_000017
Founder mutation; Carrier frequency in Iceland: 0.092% - odds ratio for colorectal cancer 2.2 (0.94-5.3); endometrial cancer 7.5 (2.4-23.5); ovarian cancer 6.6 (1.8-24.3)
PubMed: Haraldsdottir 2018
-
-
Germline
-
-
-
-
-
Sigurdis Haraldsdottir
?/.
1
c.2T>A
r.(?)
p.Met1?
-
VUS
g.6048649A>T
g.6009018A>T
-
-
PMS2_000017
Founder mutation; Carrier frequency in Iceland: 0.092% - odds ratio for colorectal cancer 2.2 (0.94-5.3); endometrial cancer 7.5 (2.4-23.5); ovarian cancer 6.6 (1.8-24.3)
PubMed: Haraldsdottir 2018
-
-
Germline
-
-
-
-
-
Sigurdis Haraldsdottir
?/.
1
c.2T>A
r.(?)
p.Met1?
-
VUS
g.6048649A>T
g.6009018A>T
-
-
PMS2_000017
Founder mutation; Carrier frequency in Iceland: 0.092% - odds ratio for colorectal cancer 2.2 (0.94-5.3); endometrial cancer 7.5 (2.4-23.5); ovarian cancer 6.6 (1.8-24.3)
PubMed: Haraldsdottir 2018
-
-
Germline
-
-
-
-
-
Sigurdis Haraldsdottir
+?/.
-
c.2T>A
r.(?)
p.(Met1?)
-
likely pathogenic
g.6048649A>T
g.6009018A>T
PMS2(NM_000535.7):c.2T>A (p.M1?)
-
PMS2_000017
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
VKGL-NL_Groningen
?/.
-
c.2T>A
r.?
p.?
-
NA
g.6048649A>T
-
chr7_6048649_A_T
-
PMS2_000017
not in 53461 controls; the study was not designed to clinically classify individual variants but performed burden-type association analyses, grouping certain variant types
PubMed: Dorling 2021 , Journal: Dorling 2021
-
-
Germline
-
2/60466 cases
-
-
-
BRIDGES consortium
+/.
-
c.2T>A
r.(?)
p.(Met1?)
-
pathogenic
g.6048649A>T
-
PMS2(NM_000535.7):c.2T>A (p.M1?)
-
PMS2_000017
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
VKGL-NL_Nijmegen
?/.
-
c.2T>C
r.?
p.?
-
NA
g.6048649A>G
-
chr7_6048649_A_G
-
PMS2_000995
the study was not designed to clinically classify individual variants but performed burden-type association analyses, grouping certain variant types
PubMed: Dorling 2021 , Journal: Dorling 2021
-
-
Germline
-
1/60466 cases
-
-
-
BRIDGES consortium
?/.
-
c.2T>C
r.?
p.?
-
NA
g.6048649A>G
-
chr7_6048649_A_G
-
PMS2_000995
the study was not designed to clinically classify individual variants but performed burden-type association analyses, grouping certain variant types
PubMed: Dorling 2021 , Journal: Dorling 2021
-
-
Germline
-
1/53461 controls
-
-
-
BRIDGES consortium
+/.
1
c.3G>A
r.0?
p.0?
-
pathogenic
g.6048648C>T
g.6009017C>T
-
-
PMS2_000388
-
-
-
-
Germline
-
-
-
-
-
Andreas Laner
?/.
-
c.4dup
r.(?)
p.(Glu2Glyfs*4)
-
NA
g.6048648dup
-
chr7_6048646_T_TC
-
PMS2_000994
not in 53461 controls; the study was not designed to clinically classify individual variants but performed burden-type association analyses, grouping certain variant types
PubMed: Dorling 2021 , Journal: Dorling 2021
-
-
Germline
-
1/60466 cases
-
-
-
BRIDGES consortium
?/.
-
c.4G>A
r.(?)
p.(Glu2Lys)
-
NA
g.6048647C>T
-
chr7_6048647_C_T
-
PMS2_000993
not in 53461 controls; the study was not designed to clinically classify individual variants but performed burden-type association analyses, grouping certain variant types
PubMed: Dorling 2021 , Journal: Dorling 2021
-
-
Germline
-
1/60466 cases
-
-
-
BRIDGES consortium
?/.
-
c.4G>C
r.(?)
p.(Glu2Gln)
-
NA
g.6048647C>G
-
chr7_6048647_C_G
-
PMS2_000992
not in 53461 controls; the study was not designed to clinically classify individual variants but performed burden-type association analyses, grouping certain variant types
PubMed: Dorling 2021 , Journal: Dorling 2021
-
-
Germline
-
1/60466 cases
-
-
-
BRIDGES consortium
?/.
-
c.8G>A
r.(?)
p.(Arg3Gln)
-
NA
g.6048643C>T
-
chr7_6048643_C_T
-
PMS2_000991
not in 53461 controls; the study was not designed to clinically classify individual variants but performed burden-type association analyses, grouping certain variant types
PubMed: Dorling 2021 , Journal: Dorling 2021
-
-
Germline
-
1/60466 cases
-
-
-
BRIDGES consortium
?/.
1
c.11C>G
r.(?)
p.(Ala4Gly)
-
VUS
g.6048640G>C
g.6009009G>C
-
-
PMS2_000018
Carrier frequency in Iceland (%): 0.04; Odds ratio for CRC (95%CI): 2.64 (0.62-11.2)
PubMed: Haraldsdottir 2018
-
-
Germline
-
0.04
-
-
-
Sigurdis Haraldsdottir
?/.
-
c.11C>G
r.(?)
p.(Ala4Gly)
-
NA
g.6048640G>C
-
chr7_6048640_G_C
-
PMS2_000018
the study was not designed to clinically classify individual variants but performed burden-type association analyses, grouping certain variant types
PubMed: Dorling 2021 , Journal: Dorling 2021
-
-
Germline
-
1/60466 cases
-
-
-
BRIDGES consortium
?/.
-
c.11C>G
r.(?)
p.(Ala4Gly)
-
NA
g.6048640G>C
-
chr7_6048640_G_C
-
PMS2_000018
the study was not designed to clinically classify individual variants but performed burden-type association analyses, grouping certain variant types
PubMed: Dorling 2021 , Journal: Dorling 2021
-
-
Germline
-
1/53461 controls
-
-
-
BRIDGES consortium
?/.
-
c.20C>G
r.(?)
p.(Ser7Trp)
-
NA
g.6048631G>C
-
chr7_6048631_G_C
-
PMS2_000990
the study was not designed to clinically classify individual variants but performed burden-type association analyses, grouping certain variant types
PubMed: Dorling 2021 , Journal: Dorling 2021
-
-
Germline
-
2/60466 cases
-
-
-
BRIDGES consortium
?/.
-
c.20C>G
r.(?)
p.(Ser7Trp)
-
NA
g.6048631G>C
-
chr7_6048631_G_C
-
PMS2_000990
the study was not designed to clinically classify individual variants but performed burden-type association analyses, grouping certain variant types
PubMed: Dorling 2021 , Journal: Dorling 2021
-
-
Germline
-
1/53461 controls
-
-
-
BRIDGES consortium
?/.
-
c.20C>T
r.(?)
p.(Ser7Leu)
-
NA
g.6048631G>A
-
chr7_6048631_G_A
-
PMS2_000989
not in 53461 controls; the study was not designed to clinically classify individual variants but performed burden-type association analyses, grouping certain variant types
PubMed: Dorling 2021 , Journal: Dorling 2021
-
-
Germline
-
1/60466 cases
-
-
-
BRIDGES consortium
-?/.
-
c.21G>C
r.(?)
p.(Ser7=)
-
likely benign
g.6048630C>G
g.6008999C>G
PMS2(NM_000535.7):c.21G>C (p.S7=)
-
PMS2_000424
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
VKGL-NL_AMC
?/.
-
c.22A>C
r.(?)
p.(Ser8Arg)
-
VUS
g.6048629T>G
-
-
-
AIMP2_000017
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
VKGL-NL_Nijmegen
?/.
-
c.22A>G
r.(?)
p.(Ser8Gly)
-
NA
g.6048629T>C
-
chr7_6048629_T_C
-
PMS2_000988
not in 53461 controls; the study was not designed to clinically classify individual variants but performed burden-type association analyses, grouping certain variant types
PubMed: Dorling 2021 , Journal: Dorling 2021
-
-
Germline
-
1/60466 cases
-
-
-
BRIDGES consortium
+?/.
-
c.23+1G>C
r.spl?
p.?
-
likely pathogenic
g.6048627C>G
-
PMS2(NM_000535.5):c.23+1G>C (p.?)
-
AIMP2_000015
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
VKGL-NL_Leiden
?/.
-
c.23+2T>G
r.spl?
p.?
-
NA
g.6048626A>C
-
chr7_6048626_A_C
-
PMS2_000987
not in 60466 cases; the study was not designed to clinically classify individual variants but performed burden-type association analyses, grouping certain variant types
PubMed: Dorling 2021 , Journal: Dorling 2021
-
-
Germline
-
1/53461 controls
-
-
-
BRIDGES consortium
-/.
-
c.23+10G>C
r.(=)
p.(=)
-
benign
g.6048618C>G
g.6008987C>G
PMS2(NM_000535.5):c.23+10G>C (p.(=), ), PMS2(NM_000535.7):c.23+10G>C
-
PMS2_000340
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
VKGL-NL_AMC
-?/.
-
c.23+10G>C
r.(=)
p.(=)
-
likely benign
g.6048618C>G
g.6008987C>G
PMS2(NM_000535.5):c.23+10G>C (p.(=), ), PMS2(NM_000535.7):c.23+10G>C
-
PMS2_000340
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
VKGL-NL_Groningen
-?/.
-
c.23+10G>C
r.(=)
p.(=)
-
likely benign
g.6048618C>G
g.6008987C>G
PMS2(NM_000535.5):c.23+10G>C (p.(=), ), PMS2(NM_000535.7):c.23+10G>C
-
PMS2_000340
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
VKGL-NL_VUmc
-?/.
-
c.23+10G>C
r.(=)
p.(=)
-
likely benign
g.6048618C>G
g.6008987C>G
PMS2(NM_000535.5):c.23+10G>C (p.(=), ), PMS2(NM_000535.7):c.23+10G>C
-
PMS2_000340
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
VKGL-NL_Utrecht
-/.
-
c.23+10G>C
r.(=)
p.(=)
-
benign
g.6048618C>G
g.6008987C>G
PMS2(NM_000535.5):c.23+10G>C (p.(=), ), PMS2(NM_000535.7):c.23+10G>C
-
PMS2_000340
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
VKGL-NL_Leiden
-?/.
1i
c.23+10G>C
r.(=)
p.(=)
-
likely benign
g.6048618C>G
g.6008987C>G
c.23+10G>C
-
PMS2_000340
-
-
-
-
Germline
-
-
-
-
-
Thomas Hansen